sulfasalazine has been researched along with Hypoproteinemia in 2 studies
Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.
Hypoproteinemia: A condition in which total serum protein level is below the normal range. Hypoproteinemia can be caused by protein malabsorption in the gastrointestinal tract, EDEMA, or PROTEINURIA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| EWE, K | 1 |
| Donald, JW | 1 |
| Donald, JG | 1 |
2 other studies available for sulfasalazine and Hypoproteinemia
| Article | Year |
|---|---|
[TREATMENT OF EXUDATIVE ENTEROPATHIES].
Topics: Drug Therapy; Gastrointestinal Diseases; Humans; Hypoproteinemia; Prednisone; Protein-Losing Enterop | 1965 |
Regional enteritis and growth retardation without intestinal symptoms.
Topics: Adolescent; Anemia, Hypochromic; Body Weight; Crohn Disease; Follow-Up Studies; Growth Disorders; Hu | 1973 |